Juanita Mary Crook

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. doi request reprint The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer
    Juanita Crook
    British Columbia Cancer Agency, Center for the Southern Interior, University of British Columbia, British Columbia, Canada
    Curr Opin Support Palliat Care 7:258-64. 2013
  2. doi request reprint Prognostic factors for newly diagnosed prostate cancer and their role in treatment selection
    Juanita Crook
    Department of Radiation Oncology, British Columbia Cancer Agency, Center for the Southern Interior, Kelowna, British Columbia, Canada
    Semin Radiat Oncol 23:165-72. 2013
  3. doi request reprint American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy
    Juanita M Crook
    Department of Radiation Oncology, British Columbia Cancer Agency, Center for the Southern Interior, Kelowna, BC, Canada
    Brachytherapy 12:191-8. 2013
  4. pmc Intermittent androgen suppression for rising PSA level after radiotherapy
    Juanita M Crook
    British Columbia Cancer Agency, Cancer Centre for the Southern Interior, 399 Royal Ave, Kelowna, BC V1Y 5L3, Canada
    N Engl J Med 367:895-903. 2012
  5. doi request reprint Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial
    Juanita Mary Crook
    University of Toronto, University Health Network, and Princess Margaret Hospital, Toronto, Ontario, Canada
    J Clin Oncol 29:362-8. 2011
  6. doi request reprint Radiation therapy for cancer of the penis
    Juanita Crook
    British Columbia Cancer Agency, Cancer Center for the Southern Interior, Department of Radiation Oncology, Kelowna, British Columbia, Canada
    Urol Clin North Am 37:435-43. 2010
  7. doi request reprint 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 80:1323-9. 2011
  8. doi request reprint The role of brachytherapy in the definitive management of prostate cancer
    J Crook
    British Columbia Cancer Agency, Center for the Southern Interior, Kelowna, British Columbia, Canada
    Cancer Radiother 15:230-7. 2011
  9. doi request reprint Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 77:1079-84. 2010
  10. doi request reprint Penile brachytherapy: technical aspects and postimplant issues
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Brachytherapy 9:151-8. 2010

Collaborators

Detail Information

Publications57

  1. doi request reprint The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer
    Juanita Crook
    British Columbia Cancer Agency, Center for the Southern Interior, University of British Columbia, British Columbia, Canada
    Curr Opin Support Palliat Care 7:258-64. 2013
    ..To review the current status of intermittent androgen suppression in the management of biochemically recurrent or newly diagnosed metastatic prostate cancer with respect to two recently reported multicenter phase III randomized trials...
  2. doi request reprint Prognostic factors for newly diagnosed prostate cancer and their role in treatment selection
    Juanita Crook
    Department of Radiation Oncology, British Columbia Cancer Agency, Center for the Southern Interior, Kelowna, British Columbia, Canada
    Semin Radiat Oncol 23:165-72. 2013
    ..The influence of each of these factors may vary depending on treatment factors such as dose, the radiation modality, or the use of concomitant androgen ablation...
  3. doi request reprint American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy
    Juanita M Crook
    Department of Radiation Oncology, British Columbia Cancer Agency, Center for the Southern Interior, Kelowna, BC, Canada
    Brachytherapy 12:191-8. 2013
    ....
  4. pmc Intermittent androgen suppression for rising PSA level after radiotherapy
    Juanita M Crook
    British Columbia Cancer Agency, Cancer Centre for the Southern Interior, 399 Royal Ave, Kelowna, BC V1Y 5L3, Canada
    N Engl J Med 367:895-903. 2012
    ..We assessed overall survival with intermittent versus continuous androgen deprivation in a noninferiority randomized trial...
  5. doi request reprint Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial
    Juanita Mary Crook
    University of Toronto, University Health Network, and Princess Margaret Hospital, Toronto, Ontario, Canada
    J Clin Oncol 29:362-8. 2011
    ..We report health-related quality of life (HRQOL) at a mean of 5.3 years for 168 trial-eligible men who either chose or were randomly assigned to RP or BT following a multidisciplinary educational session...
  6. doi request reprint Radiation therapy for cancer of the penis
    Juanita Crook
    British Columbia Cancer Agency, Cancer Center for the Southern Interior, Department of Radiation Oncology, Kelowna, British Columbia, Canada
    Urol Clin North Am 37:435-43. 2010
    ..Ideal tumors for brachytherapy should be less than 4 cm without extension onto the shaft. More advanced cases can be considered for external radiotherapy...
  7. doi request reprint 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 80:1323-9. 2011
    ..To report outcomes for 1,111 men treated with iodine-125 brachytherapy (BT) at a single institution...
  8. doi request reprint The role of brachytherapy in the definitive management of prostate cancer
    J Crook
    British Columbia Cancer Agency, Center for the Southern Interior, Kelowna, British Columbia, Canada
    Cancer Radiother 15:230-7. 2011
    ..This article will review indications and patient selection, planning and technical aspects, toxicity and efficacy for both low and high dose rate prostate brachytherapy...
  9. doi request reprint Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 77:1079-84. 2010
    ..We calculated implant quality parameters, D90 and V100, for the magnetic resonance imaging (MRI)-defined prostate plus 2, 3, and 5 mm...
  10. doi request reprint Penile brachytherapy: technical aspects and postimplant issues
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    Brachytherapy 9:151-8. 2010
    ..We report our technique that has been developed and refined over the past 20 years...
  11. doi request reprint Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 73:327-33. 2009
    ..To evaluate the effect of 3 vs. 8 months of neoadjuvant hormonal therapy before conventional-dose radiotherapy (RT) on disease-free survival for localized prostate cancer...
  12. ncbi request reprint Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Int J Radiat Oncol Biol Phys 60:15-23. 2004
    ..8 months of neoadjuvant hormonal therapy before conventional dose radiotherapy (RT) on disease-free survival using prostate-specific antigen PSA and biopsies as end points for clinically localized prostate cancer...
  13. doi request reprint Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancer
    Alfonso Gómez-Iturriaga Piña
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
    Urology 75:1412-6. 2010
    ..To report the genitourinary (GU) and gastrointestinal (GI) toxicity rates, erectile function preservation, and biochemical outcome (bNED) in men aged<or=55 years treated with 125iodine (125I) brachytherapy (BT)...
  14. doi request reprint Permanent seed brachytherapy for locally recurrent prostate cancer after radical prostatectomy: a case report and review of the literature
    Miren Gaztañaga
    Department of Radiation Oncology, British Columbia Cancer Agency, Center for the Southern Interior, University of British Columbia, Kelowna, British Columbia, Canada
    Brachytherapy 12:338-42. 2013
    ..To describe the management of a patient with locally recurrent prostate cancer in the prostate bed, 10 years after a radical prostatectomy...
  15. ncbi request reprint Locally advanced prostate cancer--biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy
    Nicholas Bruchovsky
    The Prostate Center at Vancouver General Hospital, Division of Urology, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
    Cancer 109:858-67. 2007
    ..Biochemical results from a prospective Phase II trial of intermittent androgen suppression for recurrent prostate cancer after radiotherapy were analyzed for correlations to the onset of hormone-refractory disease...
  16. ncbi request reprint Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study
    Shawn Malone
    Department of Radiation and Medical Oncology, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    BJU Int 96:514-20. 2005
    ..To assess the feasibility and tolerability of intermittent androgen suppression therapy (IAS) in prostate cancer...
  17. doi request reprint The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy
    Alfonso Gómez Iturriaga Piña
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Brachytherapy 9:213-8. 2010
    ..We report the influence of PNI in biochemical no evidence of disease (bNED) survival after (125)I prostate brachytherapy (BT)...
  18. ncbi request reprint Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy
    Daniel Taussky
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada
    Int J Radiat Oncol Biol Phys 65:358-63. 2006
    ..We analyzed the effect of postplan timing on anterior rectal-wall dose...
  19. ncbi request reprint Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation
    Juanita Crook
    Department of Radiation Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 52:453-60. 2002
    ..To look for factors predictive of acute urinary retention (AUR) after permanent seed prostate brachytherapy...
  20. ncbi request reprint Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parameters
    Nicholas Bruchovsky
    The Prostate Center at Vancouver General Hospital, Division of Urology, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada
    Cancer 107:389-95. 2006
    ..This prospective Phase II study was undertaken to evaluate intermittent androgen suppression as a form of therapy in men with localized prostate cancer who failed after they received external beam irradiation...
  21. ncbi request reprint Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion
    Daniel Taussky
    Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Int J Radiat Oncol Biol Phys 62:974-80. 2005
    ..To analyze the extent and time course of prostate edema and its effect on dosimetry after permanent seed prostate brachytherapy...
  22. doi request reprint Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy
    Alfonso Gómez-Iturriaga Piña
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 78:422-7. 2010
    ..We examined the clinical outcomes and toxicity profile of men receiving a D(90) (isodose enclosing 90% of the prostate) of ≥180 Gy...
  23. doi request reprint Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial
    Abraham Alexander
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 76:23-30. 2010
    ..1 ng/ml vs those >0.1 ng/ml...
  24. doi request reprint Effectiveness of educational intervention on the congruence of prostate and rectal contouring as compared with a gold standard in three-dimensional radiotherapy for prostate
    Ewa Szumacher
    Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 76:379-85. 2010
    ..To examine effects of a teaching intervention on precise delineation of the prostate and rectum during planning of three-dimensional conformal radiotherapy (3D-CRT) for prostate cancer...
  25. ncbi request reprint MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, Canada, M5G 2M9
    Brachytherapy 3:55-60. 2004
    ..Routine use of MRI-CT fusion reveals significant prostate edema may persist several weeks. This study evaluates the effect of edema, and its subsequent resolution, on dosimetry...
  26. ncbi request reprint Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma
    Jarad M Martin
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 69:1084-9. 2007
    ..To assess in a prospective trial the feasibility and late toxicity of hypofractionated radiotherapy (RT) for prostate cancer...
  27. ncbi request reprint Interstitial brachytherapy for penile cancer: an alternative to amputation
    Juanita Crook
    Department of Radiation Oncology, University Health Network, Princess Margaret Hospital, Toronto, Canada
    J Urol 167:506-11. 2002
    ..Interstitial brachytherapy is an effective organ sparing treatment for localized penile squamous cell carcinoma. We report results in 30 patients...
  28. ncbi request reprint PSA kinetics and PSA bounce following permanent seed prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 69:426-33. 2007
    ..To report the incidence, timing, and magnitude of the benign prostate-specific antigen (PSA) bounce after 125I prostate brachytherapy and correlate the bounce with clinical and/or dosimetric factors...
  29. ncbi request reprint Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome
    Shawn Malone
    Department of Radiation and Medical Oncology, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
    Int J Radiat Oncol Biol Phys 68:699-706. 2007
    ..To present the mature experience of a phase II trial of intermittent androgen suppression (IAS)...
  30. ncbi request reprint A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy
    Alan Nichol
    Radiation Medicine Program, Princess Margaret Hospital and University of Toronto, Toronto, Canada
    Radiother Oncol 76:11-7. 2005
    ..To prospectively evaluate toxicity, biochemical failure-free survival (bFFS) and biopsy-proven local control for prostate cancer patients treated with 75.6 Gy in 42 fractions using 6-field conformal radiotherapy to prostate alone...
  31. ncbi request reprint Iodine versus palladium for prostate brachytherapy: the controversy continues
    Juanita Crook
    Department of Radiation Oncology, University of Toronto University Health Network, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Cancer J 10:156-7. 2004
  32. ncbi request reprint The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital University Health Network, University of Toronto, Toronto, Ontario, Canada
    Brachytherapy 1:131-7. 2002
    ..We undertook to determine whether prospective measurement of the transition zone index would be predictive of either urinary retention or the severity of urinary symptoms after brachytherapy...
  33. ncbi request reprint Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Brachytherapy 1:66-73. 2002
    ..Outcome depends on implant quality, but perceived implant quality depends on accurate prostate contouring. This study documents inter observer variation in prostate contouring on post implant CT scans...
  34. doi request reprint Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer
    Seema Panchal
    University of Toronto, Toronto, Ontario, Canada
    Nat Rev Clin Oncol 6:604-7. 2009
    ..Aside from notable gynecomastia, he remained asymptomatic. He has a strong family history of breast cancer with multiple sisters affected...
  35. doi request reprint Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer
    Elantholi P Saibishkumar
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 73:61-8. 2009
    ..To compare stranded seeds (SSs) with loose seeds (LSs) in terms of prostate edema, dosimetry, and seed loss after (125)I brachytherapy...
  36. ncbi request reprint The effect of voxel size on the accuracy of dose-volume histograms of prostate 125I seed implants
    Jean François Corbett
    Department of Radiation Physics, Princess Margaret Hospital, Toronto, Ontario, Canada
    Med Phys 29:1003-6. 2002
    ..The single-seed DVH calculated by VariSeed fell below the hand calculation by up to 50% at low doses (30 Gy), and above it by over 50% at high doses (>250 Gy)...
  37. ncbi request reprint Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography
    Caitlin Gillan
    Department of Radiation Medicine, University Health Network, Princess Margaret Hospital, Toronto, Canada
    Int J Radiat Oncol Biol Phys 65:688-93. 2006
    ....
  38. ncbi request reprint Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy
    Daniel Taussky
    Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Brachytherapy 3:125-9. 2004
    ..Erectile dysfunction following permanent seed brachytherapy for prostate cancer may be related to the dose to the penile bulb. We investigated anatomic and dosimetric factors that might contribute to an increased dose to the penile bulb...
  39. ncbi request reprint Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy
    Chandra Martens
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Brachytherapy 5:9-13. 2006
    ..A relationship between pretreatment risk factors including International Prostate Symptom (IPS) score, urinary flow studies, and posttreatment urinary morbidity was assessed...
  40. ncbi request reprint Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management
    Charles Catton
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Urol Clin North Am 30:751-63. 2003
    ....
  41. ncbi request reprint Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists
    George Rodrigues
    Department of Radiation Oncology, London Regional Cancer Centre, London, Ont N6A 4L6, Canada
    Radiother Oncol 69:63-72. 2003
    ..To survey radiation oncology practice in the utilization of hormonal and radiation therapy in the primary, adjuvant and salvage treatment of localized prostate cancer...
  42. ncbi request reprint Long-term urinary sequelae following 125iodine prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada
    J Urol 179:141-5; discussion 146. 2008
    ..We describe long-term urinary function in men treated with 125iodine brachytherapy without supplemental beam irradiation...
  43. ncbi request reprint The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review
    Michael Brundage
    Kingston Regional Cancer Centre, 25 King Street West, Ontario, Canada
    Radiother Oncol 64:239-50. 2002
    ..are biochemical freedom from failure (bNED) rates, clinical recurrence-free survival, disease-specific survival and acute and late toxicity; (b) what is the appropriate dose and fractionation prescription in this clinical setting?..
  44. doi request reprint Radiation therapy in the management of the primary penile tumor: an update
    Juanita Crook
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
    World J Urol 27:189-96. 2009
    ..We have used primary penile brachytherapy as the treatment of choice for T1, T2 and selected T3 patients since 1989 and present updated results for 67 patients...
  45. ncbi request reprint Posttreatment complications of early-stage prostate cancer patients: brachytherapy versus three-dimensional conformal radiation therapy
    Grace Tsui
    R T T Department of Radiation Therapy, Princess Margaret Hospital, 610 University Hospital, Toronto, Ontario, Canada M5G 2M9
    Cancer J 11:122-32. 2005
    ..The purpose of this study was to compare treatment complications for early-stage prostate cancer managed by either brachytherapy or three-dimensional conformal radiotherapy (3D-CRT)...
  46. ncbi request reprint Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer
    Chris Parker
    Department of Biostatistics, Princess Margaret Hospital, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 58:750-7. 2004
    ..To describe the oxygenation of clinically localized prostate cancer...
  47. ncbi request reprint Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer
    Oren M Shemtov
    School of Medicine, Queen s University, Kingston, Ontario, Canada
    Can J Urol 11:2450-5. 2004
    ..We undertook to determine if any significant differences in the efficacy of sildenafil citrate for erectile dysfunction (ED) exists between patients who have received external beam radiation or brachytherapy for prostate cancer...
  48. ncbi request reprint Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer
    Marketa Skala
    Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
    Int J Radiat Oncol Biol Phys 68:690-8. 2007
    ....
  49. doi request reprint The effect of obesity on rectal dosimetry after permanent prostate brachytherapy
    Nikhilesh Patil
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada
    Brachytherapy 8:218-22. 2009
    ..We hypothesized that men with higher BMI will have a lower dose to the rectal wall and less rectal toxicity after permanent prostate implant...
  50. ncbi request reprint Surgery versus implant for early prostate cancer: what is equivalence?
    Juanita Crook
    University of Toronto Princess Margaret Hospital, Toronto, ON, Canada
    Cancer J 13:223-5. 2007
  51. doi request reprint A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion
    Alan M Nichol
    Radiation Medicine Program, Princess Margaret Hospital and University of Toronto, Toronto, Canada
    Int J Radiat Oncol Biol Phys 77:1072-8. 2010
    ..To determine the reduction of prostate motion during a typical radiotherapy (RT) fraction from a bowel regimen comprising an antiflatulent diet and daily milk of magnesia...
  52. ncbi request reprint Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial
    Kris Wallace
    Department of Radiation Medicine and the Division of Urology, Princess Margaret Hospital, University Health Network, Toronto, Canada
    J Clin Oncol 24:4158-62. 2006
    ..A multidisciplinary educational session was developed to improve patient understanding of treatment options and to facilitate accrual...
  53. doi request reprint A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy
    Juanita Crook
    Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada
    Int J Radiat Oncol Biol Phys 77:496-501. 2010
    ..We hypothesized that a cyclooxygenase-2 (COX-2) inhibitor regimen started 1 week prior to seed implant might diminish the inflammatory response, thus reducing edema, retention rates, and symptom severity...
  54. ncbi request reprint Changing management of localized prostate cancer: a comparison survey of Ontario radiation oncologists
    Jarad Martin
    Division of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada
    Can J Urol 13:26-33. 2006
    ..Annual genitourinary radiation oncology meetings aim to assist in the dissemination of knowledge that may affect current practice. We aim to measure changes in practice approaches that have occurred while these meetings have been conducted...
  55. ncbi request reprint A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer
    Andrew John Bayley
    Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University Health Network, University of Toronto, 610 University Avenue, Toronto, Ont, Canada M5G 2M9
    Radiother Oncol 70:37-44. 2004
    ....
  56. ncbi request reprint Radiation therapy and radio-nuclides for palliation of bone pain
    Juanita Crook
    Department of Radiation Oncology, University of Toronto Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada
    Urol Clin North Am 33:219-26, vii. 2006
    ..For multiple painful sites on both sides of the diaphragm, radiopharmaceuticals can be considered but will not treat adjacent soft tissue disease or neurologic compromise...
  57. ncbi request reprint Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposal
    Daniel Taussky
    Department of Radiation Oncology and Surgical Oncology, Princess Margaret Hospital and the University Health Network, University of Toronto, Toronto, Ontario, Canada
    Can J Urol 13:2978-83. 2006
    ..The literature, which consists mainly of retrospective studies of patients treated over several decades, is not conclusive. We undertook a literature review to address this issue and to propose...